Juvenile animal studies in the development of paediatric medicines: learning with 10 years experience of centralized procedure and Paediatric Investigation Plans. Drug Information Association (DIA) 22nd Annual EuroMeeting, Mónaco, March 2010.
Duarte D. 2010. Juvenile animal studies in the development of paediatric medicines: learning with 10 years experience of centralized procedure and Paediatric Investigation Plans. Drug Information Association (DIA) 22nd Annual EuroMeeting, Mónaco, March 2010.
The need for juvenile animal studies in paediatric drug development: experience from paediatric investigation plans. Presentation to the 37th Annual Meeting of the European Teratology Society, Arles, France.
Duarte D, Silva-Lima. B. 2009a. The need for juvenile animal studies in paediatric drug development: experience from paediatric investigation plans. Presentation to the 37th Annual Meeting of the European Teratology Society, Arles, France.
On the need for juvenile animal studies in paediatric drugs development: Experience from Paediatric Investigation Plans. 37th Annual Meeting of the European Teratology Society, Arles, France, September 2009.
Duarte D, Silva-Lima B. 2009b. On the need for juvenile animal studies in paediatric drugs development: Experience from Paediatric Investigation Plans. 37th Annual Meeting of the European Teratology Society, Arles, France, September 2009.
European Medicines Agency. 2008. Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications. EMEA/CHMP/SWP/169215/2005. Available at: Accessed April 28
European Medicines Agency. 2008. Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications. EMEA/CHMP/SWP/169215/2005. Available at: Accessed April 28, 2011).
(2011)
6
80051930617
European Medicines Agency. 2009. ICH Topic M 3 (R2) Note for guidance on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceutical. CPMP/ICH/286/95. Available at: Accessed April 28
European Medicines Agency. 2009. ICH Topic M 3 (R2) Note for guidance on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceutical. CPMP/ICH/286/95. Available at: Accessed April 28, 2011).
(2011)
7
80051925150
European Union. Regulation (EC) no 1902/2006 of the European Parliament and of the Council of 20 December 2006 amending Regulation 1901/2006 on medicinal products for paediatric use. Official Journal of the European Union, L 378/20.
European Union. 2006a. Regulation (EC) no 1902/2006 of the European Parliament and of the Council of 20 December 2006 amending Regulation 1901/2006 on medicinal products for paediatric use. Official Journal of the European Union, L 378/20.
(2006)
8
80051949667
European Union. Regulation (EC) no 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union, L 378/1.
European Union. 2006b. Regulation (EC) no 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union, L 378/1.
(2006)
9
78650192442
Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessors
Silva-Lima B, Due Theïlade-Thomsen M, Carleer J, et al. 2010. Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessors. Birth Defects Res B Dev Reprod Toxicol 89:467-473.
